Infections virales

MEDESIS PHARMA développe un médicament de radioprotection pour le traitement des

En savoir plus

The P42 peptide and Peptide-based therapies for Huntington’s disease_FR

Résumé La maladie de Huntington est un désordre neurodégénératif héréditaire

En savoir plus

Systemic Delivery of siRNA Down Regulates Brain Prion Protein_FR

Systemic Delivery of siRNA Down Regulates Brain Prion Protein and Ameliorates Neuropathology

En savoir plus

Phase behavior of reverse microemulsions based on Peceol®_FR

Phase behavior of reverse microemulsions based on Peceol®   Mouri A, Diat O,

En savoir plus

Water solubilization capacity of pharmaceutical microemulsions_FR

Water solubilization capacity of pharmaceutical microemulsions based on Peceol®,

En savoir plus

Development of pharmaceutical clear gel based on Peceol_FR

Development of pharmaceutical clear gel based on Peceol®, lecithin, ethanol and

En savoir plus

Development of pharmaceutical clear gel_EN

Development of pharmaceutical clear gel based on Peceol®, lecithin, ethanol and

En savoir plus

Formulation of lithium-loaded microemulsion system_FR

Formulation, physicochemical characterization and stability study of lithium-loaded

En savoir plus

In situ synthesis of Prussian blue nanoparticles

In situ synthesis of Prussian blue nanoparticles within a biocompatible reverse micellar

En savoir plus

Systemic delivery of P42 peptide_FR

Systemic delivery of P42 peptide: a new weapon to fight Huntington’s disease Yoan

En savoir plus